Director and 10% owner Scott M Rocklage sold $4.0M of Aprea Therapeutics, Inc.

Sold$4,001,461

$33.30Price

120,164Shares

−61%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Tue, Jun 16. Filed Thu, Jun 18, 3:23 PM ET, during the session. Not investment advice.